Form 8-K CNS Pharmaceuticals, For: Jan 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
CNS Pharmaceuticals (CNSP) Enters Placement Agreement
February 2, 2024 5:07 PM ESTOn January 29, 2024, CNS Pharmaceuticals (NASDAQ: CNSP) into a placement agency agreement with A.G.P./Alliance Global Partners (AGP) and Maxim Group LLC (Maxim and collectively with AGP, the Placement Agents) (the Placement Agreement) for the public offering by the Company of (i) 2,215,667 shares (the Shares) of the... More
